Agreement Between Venous and Arterial Blood Gas Measurements in the Intensive Care Unit (AVANTI)

This study has been completed.
Sponsor:
Collaborator:
Olive View-UCLA Medical Center
Information provided by:
University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT00569634
First received: December 6, 2007
Last updated: December 2, 2008
Last verified: December 2008

December 6, 2007
December 2, 2008
January 2008
July 2008   (final data collection date for primary outcome measure)
Agreement between venous and arterial blood gas measurements of pH, pCO2 and bicarbonate [ Time Frame: Duration of Intensive Care Unit Admission ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00569634 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Agreement Between Venous and Arterial Blood Gas Measurements in the Intensive Care Unit
Agreement Between Venous and Arterial Blood Gas Measurements in the Intensive Care Unit

The purpose of this study is to examine the agreement between venous blood gas and arterial blood gas measurements in patients in the Intensive Care Unit.

Venous blood gas analysis may be an alternative to arterial blood gas analysis for acid-base status, reducing the need for frequent invasive arterial sampling. The objective of this study is to examine the agreement between ABG and VBG samples for all commonly used parameters (pH, pCO2 and bicarbonate) in a pathologically diverse ICU patient population, specifically analyzing multiple paired arterial and venous samples from each patient.

Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Acid-Base Balance
Procedure: Venous blood gas analysis
When an ABG is deemed to be necessary as part of ICU management, a central venous sample will also be obtained with minimum delay (always < 2 minutes) between the samples. The samples will be analyzed by a blood gas analyzer as quickly as possible.
1
Intervention: Procedure: Venous blood gas analysis

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
July 2008
July 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Adult patients 18 years or older
  • Admitted to the Intensive Care Unit (ICU)
  • Determined by their treating clinicians to require both a central venous line and arterial line

Exclusion Criteria:

  • None
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00569634
07H-821001
Yes
Richard Treger, M.D., Olive View-UCLA Medical Center
University of California, Los Angeles
Olive View-UCLA Medical Center
Principal Investigator: Richard M Treger, M.D. Olive View-UCLA Medical Center
University of California, Los Angeles
December 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP